Peroxisome proliferator‐activated receptor‐δ induces insulin‐induced gene‐1 and suppresses hepatic lipogenesis in obese diabetic mice†
Hepatology2008Vol. 48(2), pp. 432–441
Citations Over TimeTop 10% of 2008 papers
Abstract
Our study reveals a novel mechanism by which PPARdelta regulates lipogenesis, suggesting potential therapeutic applications of PPARdelta modulators in obesity and type 2 diabetes, as well as related steatotic liver diseases.
Related Papers
- → Role of Lipogenesis Rewiring in Hepatocellular Carcinoma(2021)29 cited
- → Effects of sterol regulatory element-binding protein (SREBP) in chickens(2012)25 cited
- → Human Sterol Regulatory Element-Binding Protein 1a Contributes Significantly to Hepatic Lipogenic Gene Expression(2015)28 cited
- → Selective Proteolytic Processing of Rat Hepatic Sterol Regulatory Element Binding Protein-1 (SREBP-1) and SREBP–2 During Postnatal Development(2003)41 cited
- → Abstract 1880: Role of fatty acid synthase and do novo lipogenesis in liver cancer development in mice.(2013)